We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Association of headache, anxiety, and depression with the treatment of levetiracetam for epilepsy.
- Authors
Mantargi, Mohammad; Kondanath, Saifudheen; Ikram, Nadeem; Vigneshwaran, Easwaran; Awais, Muhammad; Thattarauthodiyil, Usman
- Abstract
The current case report bears the details of the adverse drug reactions (ADRs) associated after the administration of the levetiracetam for the management of newly diagnosed epilepsy in a female patient aged 37 years. Datum related to the patient, medications and observed ADRs were noted after getting the consent from the patient during which she has explained her experiences after the beginning of the consumption of the said drug. The Naranjo's scale and World Health Organisation, Uppsala Monitoring Centre scales analysis for the assessment of the correctness of the ADR paved for the certainty of the side effect. Drug regimen modification was initiated by the neurologist after the complaints of uneasiness from the patient after which she was identified to be complying with the other medication. Therefore, it can be said that if any patient on antiepileptic medications experiences discomfort, must bring those issues in light as there is always other options available for the management of the epilepsy without delay.
- Subjects
WORLD Health Organization; LEVETIRACETAM; DRUG side effects; ANTICONVULSANTS; EPILEPSY; DRUGS
- Publication
Saudi Journal for Health Sciences, 2021, Vol 10, Issue 2, p143
- ISSN
2278-1900
- Publication type
Article
- DOI
10.4103/sjhs.sjhs_234_20